$58.4 Million is the total value of Partner Investment Management, L.P.'s 69 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | NOVO-NORDISK A Sadr | $6,172,000 | – | 17,526 | +100.0% | 10.57% | – | |
| NXPI | New | NXP SEMICONDUCTORS N V | $2,234,000 | – | 20,473 | +100.0% | 3.82% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $2,168,000 | – | 22,136 | +100.0% | 3.71% | – |
| WDC | New | WESTERN DIGITAL CORP | $1,570,000 | – | 26,326 | +100.0% | 2.69% | – |
| XBI | New | SPDR SERIES TRUSTput | $1,251,000 | – | 16,400 | +100.0% | 2.14% | – |
| CI | New | CIGNA CORP NEW | $1,083,000 | – | 7,132 | +100.0% | 1.85% | – |
| NVS | New | NOVARTIS A Gsponsored adr | $927,000 | – | 10,711 | +100.0% | 1.59% | – |
| MKSI | New | MKS INSTRUMENT INC | $803,000 | – | 8,701 | +100.0% | 1.38% | – |
| V | New | VISA INC | $761,000 | – | 4,427 | +100.0% | 1.30% | – |
| AMD | New | ADVANCED MICRO DEVICES INC | $750,000 | – | 25,859 | +100.0% | 1.28% | – |
| PTCT | New | PTC THERAPEUTICS INC | $677,000 | – | 20,028 | +100.0% | 1.16% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $599,000 | – | 4,267 | +100.0% | 1.03% | – |
| LYV | New | LIVE NATION ENTERTAINMENT IN | $433,000 | – | 6,525 | +100.0% | 0.74% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $418,000 | – | 5,370 | +100.0% | 0.72% | – |
| VC | New | VISTEON CORP | $408,000 | – | 4,944 | +100.0% | 0.70% | – |
| MCK | New | MCKESSON CORPcall | $396,000 | – | 2,900 | +100.0% | 0.68% | – |
| GS | New | GOLDMAN SACHS GROUP INC | $324,000 | – | 1,562 | +100.0% | 0.56% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $322,000 | – | 16,731 | +100.0% | 0.55% | – |
| INSP | New | INSPIRE MED SYS INC | $217,000 | – | 3,549 | +100.0% | 0.37% | – |
| New | PTC THERAPEUTICS INCnote 3.000% 8/1 | $201,000 | – | 193,000 | +100.0% | 0.34% | – | |
| DLPH | New | DELPHI TECHNOLOGIES PLC | $190,000 | – | 14,179 | +100.0% | 0.32% | – |
| AVRO | New | AVROBIO INC | $66,000 | – | 4,669 | +100.0% | 0.11% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $57,000 | – | 19,878 | +100.0% | 0.10% | – |
| AXNX | New | AXONICS MODULATION TECH INC | $52,000 | – | 1,937 | +100.0% | 0.09% | – |
| AMK | New | ASSETMARK FINL HLDGS INC | $25,000 | – | 961 | +100.0% | 0.04% | – |
| LVGO | New | LIVONGO HEALTH INC | $25,000 | – | 1,444 | +100.0% | 0.04% | – |
| EIDX | New | EIDOS THERAPEUTICS INC | $22,000 | – | 607 | +100.0% | 0.04% | – |
| ELGXQ | New | ENDOLOGIX INC | $11,000 | – | 2,882 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 25 | Q4 2019 | 1.9% |
| HCA HOLDINGS INC | 23 | Q4 2019 | 5.4% |
| HUMANA INC | 22 | Q4 2019 | 3.5% |
| EDWARDS LIFESCIENCES CORP | 21 | Q4 2019 | 3.7% |
| CLOVIS ONCOLOGY INC | 20 | Q3 2018 | 6.6% |
| UNITEDHEALTH GROUP INC | 19 | Q4 2019 | 5.0% |
| MEDICINES CO | 19 | Q3 2018 | 3.0% |
| AERIE PHARMACEUTICALS INC | 18 | Q4 2019 | 3.1% |
| SALESFORCE COM INC | 17 | Q3 2019 | 2.7% |
| NETFLIX INC | 17 | Q2 2019 | 5.6% |
View Partner Investment Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2020-11-16 |
| 13F-NT | 2020-08-14 |
| 13F-NT | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-13 |
| 13F-HR | 2018-08-14 |
View Partner Investment Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.